DK3277266T3 - Fast oral doseringsform af amlodipin og veterinære anvendelser deraf - Google Patents
Fast oral doseringsform af amlodipin og veterinære anvendelser deraf Download PDFInfo
- Publication number
- DK3277266T3 DK3277266T3 DK16713890.8T DK16713890T DK3277266T3 DK 3277266 T3 DK3277266 T3 DK 3277266T3 DK 16713890 T DK16713890 T DK 16713890T DK 3277266 T3 DK3277266 T3 DK 3277266T3
- Authority
- DK
- Denmark
- Prior art keywords
- amlodipine
- dosage form
- oral dosage
- solid oral
- veterinary uses
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/EP2015/057194 WO2016155815A1 (en) | 2015-04-01 | 2015-04-01 | Oral solid dosage form of amlodipine and veterinary uses thereof |
| PCT/EP2016/057172 WO2016156550A1 (en) | 2015-04-01 | 2016-03-31 | Oral solid dosage form of amlodipine and veterinary uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3277266T3 true DK3277266T3 (da) | 2021-04-12 |
Family
ID=52774265
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK16713890.8T DK3277266T3 (da) | 2015-04-01 | 2016-03-31 | Fast oral doseringsform af amlodipin og veterinære anvendelser deraf |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US11147804B2 (da) |
| EP (1) | EP3277266B1 (da) |
| AU (1) | AU2016239689B2 (da) |
| CA (1) | CA2981112C (da) |
| DK (1) | DK3277266T3 (da) |
| ES (1) | ES2866029T3 (da) |
| PL (1) | PL3277266T3 (da) |
| PT (1) | PT3277266T (da) |
| SI (1) | SI3277266T1 (da) |
| WO (2) | WO2016155815A1 (da) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11452690B1 (en) | 2021-01-27 | 2022-09-27 | ECI Pharmaceuticals, LLC | Oral liquid compositions comprising amlodipine besylate and methods of using the same |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CS228917B2 (en) | 1981-03-14 | 1984-05-14 | Pfizer | Method of preparing substituted derivatives of 1,4-dihydropyridine |
| US6521647B2 (en) * | 2000-04-04 | 2003-02-18 | Pfizer Inc. | Treatment of renal disorders |
| BR0206644A (pt) * | 2001-01-26 | 2004-02-25 | Schering Corp | Combinações de inibidor(es) de absorção de esteróis com agente(s) cardiovascular(es) para o tratamento de condições vasculares |
| KR100604034B1 (ko) * | 2003-10-08 | 2006-07-24 | 주식회사유한양행 | 암로디핀 유리염기를 함유한 구강 속붕해정 및 그의 조성물 |
| EP1833466A1 (en) | 2004-12-28 | 2007-09-19 | Ranbaxy Laboratories Limited | Methods for the preparation of stable pharmaceutical solid dosage forms of atorvastatin and amlodipine |
| US20090117197A1 (en) * | 2005-03-21 | 2009-05-07 | Vicus Therapeutics Llc | Compositions and methods for ameliorating cachexia |
| WO2008062435A2 (en) * | 2006-08-15 | 2008-05-29 | Alkem Laboratories Ltd. | Stabilised dosage forms of amlodipine besylate |
| WO2009110010A2 (en) * | 2008-03-07 | 2009-09-11 | Sun Pharmaceutical Industries Ltd. | Stable oral dosage form |
| WO2011102702A2 (en) * | 2010-02-16 | 2011-08-25 | Krka, D. D., Novo Mesto | Process for the preparation of oral solid dosage forms comprising valsartan |
| IT1400309B1 (it) * | 2010-05-10 | 2013-05-24 | Menarini Int Operations Lu Sa | Associazione di inibitori della xantina ossidasi e calcio antagonisti e loro uso. |
| US9446032B2 (en) * | 2011-08-26 | 2016-09-20 | Wockhardt Limited | Methods for treating cardiovascular disorders |
| DK2811998T3 (da) * | 2012-02-06 | 2019-02-25 | Merial Inc | Parasiticide orale veterinære sammensætninger omfattende systemisk virkende aktivstoffer, fremgangsmåder og anvendelser deraf |
-
2015
- 2015-04-01 WO PCT/EP2015/057194 patent/WO2016155815A1/en active Application Filing
-
2016
- 2016-03-31 AU AU2016239689A patent/AU2016239689B2/en active Active
- 2016-03-31 SI SI201631158T patent/SI3277266T1/sl unknown
- 2016-03-31 EP EP16713890.8A patent/EP3277266B1/en active Active
- 2016-03-31 PL PL16713890T patent/PL3277266T3/pl unknown
- 2016-03-31 CA CA2981112A patent/CA2981112C/en active Active
- 2016-03-31 ES ES16713890T patent/ES2866029T3/es active Active
- 2016-03-31 PT PT167138908T patent/PT3277266T/pt unknown
- 2016-03-31 DK DK16713890.8T patent/DK3277266T3/da active
- 2016-03-31 US US15/563,300 patent/US11147804B2/en active Active
- 2016-03-31 WO PCT/EP2016/057172 patent/WO2016156550A1/en active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| AU2016239689A1 (en) | 2017-10-19 |
| SI3277266T1 (sl) | 2021-07-30 |
| US20180117023A1 (en) | 2018-05-03 |
| AU2016239689B2 (en) | 2021-06-24 |
| US11147804B2 (en) | 2021-10-19 |
| WO2016155815A1 (en) | 2016-10-06 |
| CA2981112C (en) | 2024-02-06 |
| ES2866029T3 (es) | 2021-10-19 |
| WO2016156550A1 (en) | 2016-10-06 |
| PL3277266T3 (pl) | 2021-07-05 |
| PT3277266T (pt) | 2021-04-19 |
| CA2981112A1 (en) | 2016-10-06 |
| EP3277266B1 (en) | 2021-02-17 |
| EP3277266A1 (en) | 2018-02-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3283107T3 (da) | Sammensætninger omfattende en kombination af ipilimumab og nivolumab | |
| DK3495023T3 (da) | Semifluorerede forbindelser og sammensætninger deraf | |
| DK3357513T3 (da) | Farmaceutisk sammensætning og anvendelse deraf | |
| DK3317286T3 (da) | Cykliserede sulfamoylarylamidderivater og anvendelse deraf som medikamenter til behandling af hepatitis b | |
| DK3487505T3 (da) | Indgivelse og dosering af diaminophenothiaziner | |
| DK3310371T3 (da) | Glucagon og GLP-1-Co-agonistforbindelser | |
| DK3212230T3 (da) | Dosering og indgivelse af ikke-fucosylerede anti-CD40-antistoffer | |
| DK3157508T3 (da) | Fast oral doseringsform af lipofile forbindelser | |
| DK3484469T3 (da) | Sammensætninger og fremgangsmåder til potentiering af antimikrober | |
| DK3393655T3 (da) | Fenfluramin-sammensætninger og fremgangsmåder til fremstilling af samme | |
| DK3220750T3 (da) | Oral rehydreringssammensætning og fremgangsmåder dertil | |
| DK3102200T3 (da) | Terapeutisk forbindelse og sammensætning | |
| DK3331879T3 (da) | Benzazolforbindelser og fremgangsmåder til fremstilling og anvendelse af forbindelserne | |
| DK3278803T3 (da) | Fast farmaceutisk doseringsform af PARP-inhibitor, og anvendelse af fast farmaceutisk doseringsform af PARP-inhibitor | |
| DK3067575T3 (da) | Skrue til undgåelse af revner og grater | |
| DK3255042T3 (da) | Heterocyklisk forbindelse og farmaceutisk sammensætning omfattende samme | |
| DK3319609T3 (da) | Sammensætninger og fremgangsmåder til anvendelse af antibakterielle lægemiddelkombinationer | |
| DK3380525T3 (da) | Farmaceutiske formuleringer og fremgangsmåder til anvendelse deraf | |
| DK2958573T3 (da) | Farmaceutiske formuleringer af nitrit og anvendelser deraf | |
| DK3275453T3 (da) | Farmaceutisk sammensætning med silibinin og ve | |
| DK3256479T3 (da) | 4-substituerede benzoxaborolforbindelser og anvendelser deraf | |
| DK3288379T3 (da) | Peptidsammensætninger og anvendelsesmåder | |
| DK3310331T3 (da) | Injicerbare farmaceutiske formuleringer af lefamulin | |
| DK3383397T3 (da) | Farmaceutiske sammensætninger indeholdende doravirin, tenofovirdisoproxilfumarat og lamivudin | |
| DK2968174T3 (da) | Dobbelt anvendelige orale tabletter af farmaceutisk sammensætning af sulfatsalte og fremgangsmåder til anvendelse deraf |